Clinical Trials

Endometrial Cancer

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 3 of 3 Clinical Trials Related to Endometrial Cancer

Clinical Research Trial

MSK 20-067 Endometrial Cancer

SEntinel Lymph node Endometrial Cancer Trial: A Prospective Multicenter International Single-Arm Observational Trial(SELECT)

Clinical Research Trial

NRG GY018

A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer

Doctor(s) Running This Study
Clinical Research Trial

NRG GY-014

A Phase II Study of Tazemetostat (EPZ-6438) (IND # 138671) in Recurrent or Persistent Endometrioid or Clear Cell Carcinoma of the Ovary, and Recurrent or Persistent Endometrioid Endometrial Adenocarcinoma

Doctor(s) Running This Study